Colored points, show dates from the parametric test where events observed in Fig 9 have a <i>p</i>-value below the <i>α</i> = 0.05 and then geometric model for any <i>p</i> can not... by Héctor Raúl Olivares-Sánchez (13014866)

Platelet count of all individuals and the mean concentration of each group with 95%CI on each day after enrolment. by Nattapat Nitinai (17896679)

Subjects:

AST concentrations of all individuals and the mean concentration of each group with 95%CI on each day after enrolment. by Nattapat Nitinai (17896679)

Subjects:

Hematocrit of all individuals and the mean concentration of each group with 95%CI on each day before the peak values. by Nattapat Nitinai (17896679)

Subjects:

ALT concentrations of all individuals and the mean concentration of each group with 95%CI on each day after enrolment. by Nattapat Nitinai (17896679)

Subjects:

INCOME INEQUALITY DECREASE DETERMINANTS IN BRAZILIAN REGIONS BETWEEN 2001 AND 2015 by Marina Guazzelli Saad (10391918)

“…<p></p><p>This paper aims to systematize the explanations for income inequality decreases observed in Brazil between 2001 and 2015, analyzing each region and subperiod separately and focusing on social programs. …”

Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome by Courtney Townsel (6705368)

Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients by A.R. Brunoni (5694239)

“…After adjusting for clinical and demographic variables, significantly decreased BNDF plasma levels were observed in psoriasis patients (P=0.01) (estimated marginal means of 3922 pg/mL; 95%CI=2660-5135) compared with controls (5788 pg/mL; 95%CI=5185-6442). …”

Evaluation results of the calibration data from the different observed data combinations in Exp.1 and Exp. 3. by Yonghui Zhang (279832)

Subjects:

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

Subjects:

ALT concentrations of all individuals and the mean concentration of each group with 95%CI on each day before maximum concentrations. by Nattapat Nitinai (17896679)

Subjects:

Platelet count of all individuals and the mean concentration of each group with 95%CI on each day before the peak values. by Nattapat Nitinai (17896679)

Subjects:

AST concentrations of all individuals and the mean concentration of each group with 95%CI on each day before maximum concentrations. by Nattapat Nitinai (17896679)

Subjects:

Mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects: